The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
E xcitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently ...
Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite ... suppressing appetite and stimulating weight loss. Nausea is a commonly reported side effect.
GLP-1 medications are breakthroughs for weight loss, diabetes, and more. Pharma companies are clamoring to produce pills or ...
The new anti-obesity ... in terms of weight loss (up to -8.3% from baseline) were also observed on the 57th day of follow-up, 4 weeks after the administration of the last pill.
A new weight loss drug developed by Amgen may provide better results with fewer injections than current treatments such as Ozempic and Wegovy, according to the results of a recent trial.